Case Study: SRC
About the Company
SRC Cancer Research Society is a non-profit organization dedicated to advancing cancer research. The organization has been a leader in the field, developing new treatments and techniques, raising awareness of early detection and prevention, and providing support to those affected by cancer. Its commitment to the cause has made it a formidable force in the fight against this devastating disease.
Idea
SRC needed their platform to be taken over and maintained to insure a constant access to information and resources.
The Challenge
The Joomla! platform, based on an old technology, needed to be regularly updated to limit risks and ensure the website's viability.
The Solution
Nixa provides both proactive and reactive support to its customers. Proactively, we are recommending frequent updates and adjustments to ensure that SRC’s website is always up-to-date with the latest versions. Reactive support is available in case of emergency situations, offering a fast response to any unexpected issues that may arise. This ensures customers can rest assured knowing that any issues can be quickly and effectively resolved. Nixa recognizes the importance of providing both proactive and reactive support, as it ensures their customers are provided with the highest quality of serv
The Result
The mission of the Cancer Research Society is so important that it affects the whole population. Nixa is proud to be able to contribute in its own way to advancing research on the disease by informing the population.
Marc F. Adam, CEO of Nixa
Php
Joomla
Jquery
Html5
Css3
JavaScript
Sass
Nixa is a specialized programming firm, expert in complex and custom web development. Based in downtown Montreal, Nixa provides web and application development services to businesses and organizations around the world in search of quality and performance.
The mission of the Cancer Research Society is so important that it affects the whole population. Nixa is proud to be able to contribute in its own way to advancing research on the disease by informing the population.
Marc F. Adam, CEO of Nixa